University of Southern California Norris Comprehensive Cancer Center is a clinical research site located in Los Angeles, California, United States.
Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.
University of Southern California Norris Comprehensive Cancer Center has participated in 16 clinical trials with 6 currently active.
Therapeutic areas: Urinary Bladder Cancer, Polycythemia Vera, Chronic Graft-versus-host-disease.
Sponsors: Taris Biomedical LLC, Kartos Therapeutics, Inc., Syndax Pharmaceuticals.
Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
University of Southern California Norris Comprehensive Cancer Center has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Southern California Norris Comprehensive Cancer Center has 16 clinical trials on record, with 6 currently active. Their work covers Urinary Bladder Cancer, Polycythemia Vera, Chronic Graft-versus-host-disease.
Yes — University of Southern California Norris Comprehensive Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.